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Tumor necrosis factor-␣ (TNF) activates caspase-8 to cleave
effector caspases or Bid, resulting in type-1 or type-2 apoptosis,
respectively. We show here that TNF also induces caspase-8-dependent C-terminal cleavage of the retinoblastoma protein
(Rb). Interestingly, fibroblasts from RbMI/MI mice, in which the
C-terminal caspase cleavage site is mutated, exhibit a defect in
Bid cleavage despite caspase-8 activation. Recent results suggest
that TNF receptor endocytosis is required for the activation of
caspase-8. Consistent with this notion, inhibition of V-ATPase,
which plays an essential role in acidification and degradation of
endosomes, specifically restores Bid cleavage in RbMI/MI cells.
Inhibition of V-ATPase sensitizes RbMI/MI but not wild-type
fibroblasts to TNF-induced apoptosis and stimulates inflammation-associated colonic apoptosis in RbMI/MI but not wild-type
mice. These results suggest that Rb cleavage is required for Bid
cleavage in TNF-induced type-2 apoptosis, and this requirement can be supplanted by the inhibition of V-ATPase.

Tumor necrosis factor-␣ (TNF)2 is an inflammatory cytokine
that orchestrates the systemic responses to infections and injuries. Discovered as an inducer of tumor necrosis, TNF also promotes tumor development, particularly under conditions of
chronic inflammation (1–3). The tumor-promoting activity of
TNF is mediated through its activation of the NF-B pathway,
which stimulates the production of cytokines, chemokines, and
apoptotic inhibitors (4, 5). Nonetheless, the type-1 TNF receptor (TNFR1) contains a death domain (DD) that can induce the
assembly of death-inducing signaling complex (DISC) to acti-
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vate the initiator caspase-8, leading to the induction of apoptosis (6, 7). TNFR1 also activates programmed necrosis that is
independent of caspase activity but mediated by reactive oxygen species (8 –10). The prodeath function of TNF is observed
when the NF-B pathway is inactivated. In ex vivo experiments,
cycloheximide (CHX) is routinely used to divert TNF signal
toward death by blocking the expression of NF-B-induced
genes, such as FLIP and mitochondrial superoxide dismutase,
that prevent the activation of caspase-8 and the generation of
reactive oxygen species, respectively (11, 12). In cells defective
in the NF-B pathway, TNF alone (without CHX) is sufficient
to induce cell death (13, 14). In mice, TNF- and TNFR1-dependent cell death is observed in a variety of mouse tissues
under conditions of acute inflammation (2, 5, 15). The molecular mechanisms that govern the survival versus the death
response to TNF are likely to be complex and have not been
fully elucidated.
An important clue to how TNF differentially activates NF-B
or caspase-8 has come from recent studies showing that TNFR1
endocytosis is a prerequisite for DISC assembly (16, 17). In the
plasma membrane, activated TNFR1 is capable of stimulating
the NF-B pathway, but it does not associate with FADD or
caspase-8 (18, 19). By contrast, two other DD receptors (i.e.
FAS/CD95 and DR5) do assemble DISC at the plasma membrane when activated by FAS ligand or TRAIL, respectively
(19). In experiments conducted with a human fibrosarcoma cell
line (HT1080) that expresses a degradation-resistant IB-␣ to
divert TNF signal toward caspase-8, Micheau and Tschopp (18)
detected a cytosolic DISC complex containing TRADD, FADD,
and caspase-8 but free of TNFR1. Subsequent studies conducted
with human U937 and mouse 3T3 cells detected TNFR1-associated TRADD-FADD-caspase-8 complex in the endosomal fraction (16). Together, these results suggest that TNFR1 endocytosis
and the release of DISC from the receptor-endosome may play a
role in determining the cellular response to TNF.
The retinoblastoma susceptibility gene product, Rb, is a
nuclear scaffolding protein with multiple protein-binding
pockets (20 –23). Rb inhibits the transcription of E2F-regulated
genes to block cell cycle progression. Because E2F also stimulates the expression of apoptotic factors, such as caspases and
Apaf-1, inhibition of E2F by Rb confers apoptotic resistance in
growth-arrested cells (24). Upon stimulation with mitogenic
factors, Rb is inactivated through phosphorylation by cyclindependent kinases to promote cell cycle entry and S-phase progression (25). Upon exposure to death stimuli, Rb is cleaved by
caspase at a predominant site, DEAD886G887, near the C termiJOURNAL OF BIOLOGICAL CHEMISTRY
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nus of the protein (26 –28). Cleavage at this site generates a
large fragment of Rb (Rb⌬I) that retains E2F-binding and transcription repression functions (26, 27, 29). Thus, the C-terminal cleavage does not interfere with the antiproliferative activity
of Rb. We have mutated this C-terminal caspase cleavage site to
DEAA886E887 in the mouse Rb gene to create the Rb-MI allele
(30). The Rb-MI allele confers resistance to inflammation-induced apoptosis in the mouse intestine, which is dependent on
TNF (30). The Rb-MI allele also confers resistance to TNFinduced apoptosis in explanted thymocytes and in fibroblasts
derived from the mouse embryos (30, 31). Interestingly, however, Rb-MI does not protect fibroblasts from apoptosis
induced by TRAIL3; nor is it protective of hepatocyte apoptosis
induced by the ligation of FAS receptor.4
Death receptors, such as FAS and TNFR1, stimulate apoptosis through two pathways, both activated by caspase-8 (4, 32). In
the type-1 pathway, initiator caspase-8 directly cleaves and activates effector caspases to induce apoptosis (33). In the type-2
pathway, initiator caspase-8 cleaves Bid, and the resulting tBid
induces mitochondria outer membrane permeability to cause
the release of proapoptotic factors, leading to the activation of
apoptosome and caspase-9 (33, 34). We have previously shown
that TNFR1-induced cytochrome c release is defective in
Rb-MI fibroblasts (30). In pursuing the mechanism underlying
this defect, we have discovered that inhibition of vacuolar
ATPase can restore the TNFR1-induced type-2 apoptotic pathway in Rb-MI cells.
The vacuolar ATPase (V-ATPase) is a proton pump that is
conserved in eukaryotic cells (35, 36). Composed of a soluble V1
complex that hydrolyzes ATP and an integral membrane V0
complex that forms the proton channel, V-ATPase couples
ATP hydrolysis to the translocation of protons from the cytosol
to the lumen of late endosomes, multivesicular bodies, and
lysosomes (35, 37). V-ATPase-dependent luminal acidification
provides the necessary condition for lysosomal degradative
enzymes to perform their functions. Moreover, acidification is also
required for endosomal trafficking (37, 38), best demonstrated by a
recent report that V-ATPase allows the recruitment of Arf6 and
ARNO to the endosomal membrane for sorting to the multivesicular body and lysosome (39). We show here that TNFR1 activates the 43-kDa endosomal caspase-8 in Rb-MI cells, but Bid is
not cleaved. However, Bid cleavage is rescued either by the knockdown of Rb-MI or by the inhibition of V-ATPase.

B. N. Chau and J. Y. J. Wang, unpublished results.
T.-T. Chen and J. Y. J. Wang, unpublished results.

Antibodies and Chemicals—Rb antibodies used are rabbit
anti-Rb (851) raised against the C-terminal fragment (residues
768 –928) of Rb (20) and anti-Rb from Pharmingen (554136);
rat anti-caspase-8 (1G12) and rat anti-FADD (12E7) were from
Alexis Biochemicals; rabbit anti-Smac was from Chemicon;
goat anti-Bid and rabbit anti-Cox-IV were from Biovision; goatanti-ATP6V1B1 (N-20), rabbit-anti-Mcl-1 (S-19), and rabbit
anti-TRADD (H-278) were from Santa Cruz Biotechnology,
Inc. (Santa Cruz, CA); rabbit anti-phospho-c-Jun, mouse anticleaved caspase-3 (5A1), and rabbit anti-PARP1 were from Cell
Signaling Technology; mouse anti-cytochrome c antibody was
from BD Biosciences; biotin-VAD-fmk was from Kamiya; the
caspase-8 fluorometric assay kit was from Biovision; the caspase-3
fluorometric assay kit was from Molecular Probes; the TUNEL
staining kit was obtained from BD Biosciences; recombinant
human and mouse TNF were from R & D Systems; MG-132 and
cathepsin inhibitor benzyloxycarbonyl-YY-fmk were from Calbiochem; and bafilomycin A1, concanamycin A, and carbonyl cyanide
4-(trifluoromethoxy)phenylhydrazone (FCCP) were from Sigma.
Western Blot—Whole cell lysates were prepared in radioimmune precipitation buffer (50 mM Tris-HCl (pH 7.4), 150 mM
NaCl, 1% Nonidet P-40, 0.25% sodium deoxycholate, 0.1% SDS,
0.5 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol) plus protease
inhibitor (from Sigma); 50 –100 g of total protein were
resolved by SDS-PAGE, transferred onto polyvinylidene difluoride membranes, blocked in 5% nonfat dry milk/TBST (20 mM
Tris-HCl (pH 7.5), 150 mM NaCl, 0.05% Tween 20), and incubated with primary antibodies overnight at 4 °C. Membranes
were washed three times for 10 min each in TBST and incubated with horseradish peroxidase-conjugated secondary antibodies for 1–3 h at room temperature. After three 10-min
washings, membranes were incubated with enhanced ECL reagent (from Pierce) for 1 min and exposed to x-ray films. To
detect Rb protein in MEFs, 5 g of anti-Rb (851) was mixed with
1 mg of whole cell lysate, and the immune complex was collected on protein A-Sepharose, resolved by SDS-PAGE, and
then immunoblotted with anti-Rb antibody from Pharmingen.
Propidium Iodide Uptake—Cells were trypsinized and resuspended in 500 l of phosphate-buffered saline containing 1
g/ml propidium iodide, incubated for 10 min at room temperature, and immediately analyzed by flow cytometry, counting at
least 10,000 events/sample. For each treatment condition, triplicate samples were analyzed, from which the average percentage of propidium iodide-positive cells was calculated.
DEVDase and IETDase Assay—Cells were lysed in PIPES/
CHAPS buffer (10 mM HEPES-KOH (pH 7.5), 10 mM KCl, 1.5
mM MgCl2, 1 mM EDTA, 1 mM EGTA) and clarified by centrifugation. 100 g of total protein was incubated with 50 M AcDEVD-AMC or Ac-IETD-AFC for 60 min at 37 °C. Fluorometric detection of AMC and AFC was performed in triplicates by
excitation at 360 nm/emission at 460 nm (AMC) or excitation
at 400 nm/emission at 505 nm (AFC).
Cell Fractionation—Cells were trypsinized, washed in phosphate-buffered saline, resuspended in mannitol/sucrose buffer
(210 mM mannitol, 70 mM sucrose, 10 mM HEPES (pH 7.5), 0.5
mM EDTA) plus protease inhibitor and broken up by passage
through a 22.5-gauge needle. Heavy membrane fractions (containing mitochondria) were pelleted by centrifugation. 100 g
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EXPERIMENTAL PROCEDURES
Cell Culture—Fibroblasts derived from Rb⫹/⫹ (Rb-wt) and
RbMI/MI (Rb-MI) mouse embryos were immortalized through
the 3T3 passage protocol. The Caspase-8⫺/⫺ and Caspase8⫹/⫹ MEFs (40) were gifts from Dr. David Wallach (Weizmann
Institute, Israel). MEFs were cultured in Dulbecco’s modified
Eagle’s medium containing 10% fetal bovine serum, penicillin/
streptomycin, and 0.05% ␤-mercaptoethanol. Cells were routinely treated with 10 ng/ml recombinant human TNF (hTNF)
plus 2.5 g/ml CHX for 5 h at 37 °C unless noted otherwise.

3
4
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of the supernatant was resolved on a 14% SDS-polyacrylamide
gel followed by immunoblotting with anti-cytochrome c or
anti-Samc.
In Vitro Cytochrome c Release Assay—Freshly isolated liver
mitochondria were combined with cytosolic extracts from
untreated or TNF-treated Rb-wt or Rb-MI cells diluted in KCl
buffer (125 mM KCl (pH 7.4), 10 mM HEPES-KOH, 5 mM
Na2HPO4, 4 mM MgCl2, 0.5 mM EGTA) and incubated for 45
min at 37 °C under gentle agitation. Mitochondria were pelleted by centrifugation. The supernatants and the pellets were
separately analyzed for cytochrome c and Cox-IV by
immunoblotting.
In Vivo Affinity Labeling of Caspase-8—We adopted the
method described by Tu et al. (41) to label activated caspase-8
in cells. Briefly, 1 ⫻ 107 cells were trypsinized, centrifuged, and
resuspended in 4 ml of Dulbecco’s modified Eagle’s medium
containing 10% fetal bovine serum with 50 M biotin-VADfmk. After 1 h of incubation at 37 °C, 10 ng/ml hTNF plus CHX
(2.5 g/ml) were added. Cells were harvested at the indicated
time and lysed in 0.5 ml of radioimmune precipitation buffer,
and 1 mg of total proteins were incubated with 50 l of streptavidin/Sepharose beads (Amersham Biosciences) at 4 °C overnight. The beads were washed with radioimmune precipitation
buffer and boiled in 25 l of 3⫻ SDS sample buffer, the supernatant was resolved by SDS-PAGE, and caspase-8 was detected
by immunoblotting.
Synchronization of Endocytosis—Rb-wt or Rb-MI cells were
first incubated with different doses of hTNF/CHX at 4 °C for 90
min and then shifted to 37 °C for different amounts of time.
Cells were subjected to either cell death assay by propidium
iodide uptake or DEVDase and IETDase assay.
Dextran Sulfate Sodium (DSS)-induced Colonic Apoptosis in
Mice—Rb⫹/⫹, Rb⫹/MI, or RbMI/MI mice were fed water containing 3% DSS (Mr 36,000 –50,000 from Sigma). At 56 h into DSS
feeding, they were injected intraperitoneally with either bafilomycin A1 at a concentration of 25 ng/g body weight or vehicle.
Mice were sacrificed 16 h later, and colonic tissues were collected in a roll, fixed in 4% paraformaldehyde for 2 days, embedded into paraffin blocks, cut into 5-m sections, deparaffined,
and TUNEL-labeled. Fluorescent images of labeled sections
were captured by CCD camera; TUNEL-positive nuclei were
counted in at least 25 crypts per tissue samples. All animal studies were approved by the University of California San Diego
institutional animal care and use committee.
Lysosomal pH Measurement—We adopted the method
described by Trombetta et al. (42) to measure the luminal pH of
endosomes and lysosomes. Briefly, 10,000 Rb-wt or Rb-MI
mouse fibroblasts were plated per well in a 96-well plate. After
overnight culture, cells were loaded with the pH-sensitive
FITC-dextran (Sigma) for 1 h at 37 °C, followed by treatment
with hTNF/CHX or bafilomycin A1 (200 nM) for 5 h. At the end
of the experiment, excess FITC-dextran was removed by extensive washing with Dulbecco’s modified Eagle’s medium, and the
wells were replaced with phosphate-buffered saline. The fluorescence emitted at 520 nm was recorded at two excitation
wavelengths, 450 and 490 nm, using a SpectraMax Gemini fluorescence plate reader. The pH values were determined by
comparing the fluorescence signals with a standard curve conOCTOBER 5, 2007 • VOLUME 282 • NUMBER 40

structed for FITC-dextran in phosphate/citrate buffers of different pH values between 4.0 and 8.0.
DNA Microarray—Rb-MI or Rb-wt cells were subjected to
different treatments, and then the total RNA was extracted, and
the cRNA probes were synthesized and labeled with biotin (for
Affymetrix GeneChip威 (MGU74A)) or Cy5 or Cy3 (for Agilent
mouse whole genome array (G4112A)). Array hybridization,
data collection, and analysis were conducted using protocols
and programs supplied by the manufacturers and indicated in
the figures and tables.
siRNA Experiments—Sense and antisense RNA oligonucleotides corresponding to the target sequence for mouse Rb
(GUUGAUAAUGCUAUGUCAA), mouse ATP6V1B1 (TCCACCTCAGTCCTATATA), and LacZ (AACGTACGCGGAATACTTCGA) were synthesized and annealed by Ambion.
Uniqueness of individual target sequences was confirmed by a
BLAST search of the mouse genomic plus transcript data base.
Transfection of synthetic siRNA was performed using Lipofectamine reagent with standard procedures. 48 h after transfection, cells were collected, and target protein levels were
analyzed. Cotransfection of Cy3-labeled siRNA duplexes was
performed to determine transfection efficiency when
necessary.

RESULTS
TNFR1-induced Type-2 Apoptotic Pathway Is Blocked in
Rb-MI Cells—We have previously shown that Rb-MI mouse
fibroblasts are resistant to apoptosis induced by the type-1 TNF
receptor (TNFR1), which is activated by human TNF or an antiTNFR1 agonist antibody (30). Consistent with previous results,
hTNF (activates only the mouse TNFR1) or mouse TNF/CHX
(mTNF; activates TNFR1 and R2) led to caspase activation
measured by the cleavage of DEVD-AMC or IETD-AFC in
Rb-wt cells (Fig. 1, A and B). In Rb-MI fibroblasts, mTNF/CHX
but not hTNF/CHX caused caspase activation (Fig. 1, A and B).
We also measured the IETDase activity, which is mostly mediated by caspase-8 (43), at several concentrations of mTNF and
hTNF. With the Rb-wt cells, the half-maximum IETDase measured at 5 h after stimulation was observed at a ⬃10 ng/ml concentration of either hTNF or mTNF, although the maximal
levels of IETDase were higher in mTNF/CHX-treated Rb-wt
cells. With the Rb-MI cells, the IETDase activity stimulated by
mTNF/CHX was about 2-fold lower than that found in Rb-wt
cells at every mTNF concentration tested (Fig. 1C). With hTNF,
however, Rb-MI cells appeared nonresponsive, with no detectable stimulation of IETDase at hTNF concentrations up to 80
ng/ml (Fig. 1C).
We have previously shown that hTNF/CHX-induced cytochrome c release is defective in Rb-MI cells (30). As shown in
Fig. 1D, cytosolic Smac and cytochrome c were detected in
Rb-wt cells treated with hTNF/CHX or mTNF/CHX, but their
release only occurred in mTNF/CHX-treated Rb-MI cells. Consistent with the role of Bid cleavage in TNF-induced cytochrome c release (34, 44), we observed Bid cleavage in Rb-wt
cells treated with hTNF/CHX or mTNF/CHX, but Bid was only
cleaved in mTNF/CHX-treated Rb-MI cells (Fig. 1E). To further examine the cytochrome c release defect in Rb-MI cells, we
prepared lysates from hTNF/CHX-treated Rb-wt and Rb-MI
JOURNAL OF BIOLOGICAL CHEMISTRY
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cells and incubated them with liver mitochondria. Cytochrome
c release activity was detected in lysates from hTNF/CHXtreated Rb-wt cells but not those from Rb-MI cells (Fig. 1F). The
lysates of Rb-MI cells, either before or after hTNF/CHX treatment, did not interfere with cytochrome c release induced by a
recombinant NC-Bid (45) (Fig. 1G), suggesting that the defect is
not caused by an inhibitor of tBid in Rb-MI lysates. In keeping

29404 JOURNAL OF BIOLOGICAL CHEMISTRY

with this conclusion, we found that hTNF/CHX induced similar modifications of Mcl-1, an inhibitor of cytochrome c release,
in Rb-wt and Rb-MI cells (supplemental Fig. 1B). We also prepared liver mitochondria from Rb-MI mice and found them to
be competent in releasing cytochrome c in response to lysates
from hTNF/CHX-treated Rb-wt fibroblasts (Fig. 1H). Taken
together, these results show that TNFR1-induced Bid cleavage
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is defective in Rb-MI cells and that the lack of tBid rather than
the accumulation of inhibitors accounted for the cytochrome c
release defect in hTNF/CHX-treated Rb-MI cells.
TNFR1-induced Cleavage of Rb Requires Caspase-8—TNFinduced Bid cleavage is dependent on caspase-8 (34, 44). Likewise, TNFR1-induced Rb cleavage is also dependent on
caspase-8 (Fig. 2, A–D). Treatment with hTNF/CHX did not
cause the cleavage of Rb, PARP1, or caspase-3 in fibroblasts
derived from caspase-8 knock-out mouse (Fig. 2B); nor did it
activate the DEVDase or IETDase activity (Fig. 2, C and D).
Cleavage of Rb, PARP1, and caspase-3 and activation of DEVDase or IETDase in response to hTNF/CHX occurred in fibroblasts from Caspase-8⫹/⫹ littermates (Fig. 2, B–D). Since
caspase-8 is required for TNFR1 to induce the cleavage of Rb
and Bid, and since Bid cleavage is defective in Rb-MI cells, our
results (Figs. 1 and 2) suggest that Rb cleavage is required for
Bid cleavage.
TNFR1-induced Bid Cleavage Is Restored by the Knockdown
of Rb-MI—To demonstrate that the Rb-MI protein is required
to prevent Bid cleavage, we used siRNA to knockdown its
expression (Fig. 2E). The knockdown of wild type Rb protein
did not enhance hTNF/CHX-induced IETDase activity, Bid
cleavage, or cell death (Fig. 2, F–H). In contrast, knockdown of
Rb-MI restored hTNF/CHX-induced IETDase activity, Bid
cleavage, and cell death (Fig. 2, F–H). These results suggest that
Rb cleavage is sufficient to promote TNFR1-induced Bid cleavage, because the knockdown of Rb does not further enhance Bid
cleavage. By contrast, the Rb-MI protein, which cannot be
cleaved, blocks Bid cleavage. Furthermore, the Rb-MI protein
must be present to prevent TNFR1 from inducing the cleavage
of Bid, because Bid cleavage is restored with the knockdown of
Rb-MI.
TNF-induced Gene Expression Is Similar in Rb-wt and Rb-MI
Cells—Given the established role of Rb in the regulation of gene
expression, we performed microarray analyses to compare gene
expression profiles of Rb-MI cells treated with hTNF/CHX versus mTNF/CHX. However, we did not detect any statistically
significant differences despite the fact that mTNF/CHX, but
not hTNF/CHX, induced Bid cleavage in Rb-MI cells (supplemental Fig. 2 and Table 1). We also compared hTNF/CHXinduced gene expression changes in Rb-wt and Rb-MI cells and
found a similar cohort of up-regulated and down-regulated
genes in these two cell lines (supplemental Table 2). We have
previously observed hTNF/CHX-induced IB-␣ degradation in

Rb-wt and Rb-MI cells (30), consistent with the similar up-regulation of several known NF-B regulated genes by TNF in
these cells (supplemental Table 2). We also found that hTNF/
CHX-induced phosphorylation of c-Jun was similar in Rb-wt
and Rb-MI cells (supplemental Fig. 1A). Thus, Rb-MI did not
exert a detectable effect on TNF-induced gene expression,
which is mediated by the TNFR1 at the plasma membrane.
Moreover, a Bid cleavage defect in Rb-MI cells is not likely to
require new gene expression, since it is observed in the presence of CHX.
Activation of Caspase-8 in Rb-MI Cells—We have previously
observed the loss of full-length caspase-8, occurring between 12
and 24 h after hTNF/CHX treatment in both Rb-wt and Rb-MI
primary fibroblasts (30), indicating that caspase-8 activation is
not impaired in Rb-MI cells. With the immortalized Rb-wt and
Rb-MI fibroblasts, we could not detect any reduction in fulllength caspase-8 at 5 h after hTNF/CHX treatment when Bid
cleavage was observed (Fig. 3A). Since caspase-8 activation does
not require its cleavage (46, 47), we adopted an in vivo affinity
labeling method to covalently biotinylate activated caspase-8
with a membrane-permeable biotin-VAD-fmk (41) (Fig. 3B).
The full-length (p55) caspase-8 was pulled down by streptavidin beads only in cells exposed to biotin-VAD-fmk (not shown),
and this p55 band was not found in caspase-8⫺/⫺ fibroblasts
(Fig. 3C). The levels of biotinylated p55 caspase-8 were similar
in untreated and hTNF/CHX-treated cells (Fig. 3, C and D).
Detection of active caspase-8 in untreated cells may not be
surprising, given the recent finding that caspase-8 has biological functions other than the stimulation of apoptosis (48,
49). At 2 h after hTNF/CHX addition, a p43 caspase-8 band
was pulled down in cells with caspase-8 but not in the
Caspase-8⫺/⫺ cells (Fig. 3, C and D). Previous studies have
shown that the p43 caspase-8 is present in the endosomal
fraction of TNF-treated cells (16). Approximately 1% of the
input p55 band was pulled down by the streptavidin beads
(Fig. 3D), and the p43 band could not be detected in whole
cell lysates (Fig. 3A), indicating that only a small fraction of
the full-length caspase-8 was activated and converted to p43
in response to hTNF/CHX. We observed biotinylated p55
and p43 bands in hTNF/CHX-treated Rb-wt and Rb-MI cells
(Fig. 3D), consistent with the previous conclusion that
TNFR1-induced caspase-8 activation does occur in Rb-MI
cells.

FIGURE 1. TNFR1-induced type-2 apoptotic pathway is blocked in Rb-MI MEFs. A and B, DEVDase (A) and IETDase (B) activities were not activated by
hTNF/CHX in Rb-MI MEFs. The protease activities in whole cell lysates were measured at 5 h after the indicated treatments. Activity in untreated lysate was set
to 1 for each cell type. Values are mean and S.E. from three independent experiments. C, IETDase dose response to hTNF/CHX or mTNF/CHX. Rb-MI or Rb-wt cells
were treated with the indicated concentrations of hTNF or mTNF plus CHX (2.5 g/ml). The IETDase activity in whole cell lysates was measured at 5 h after the
indicated treatments, and the activity in untreated lysates was set to 1. Values are mean and S.E. from three independent experiments. D, cytosolic cytochrome
c (Cyto c) and Smac were not detected in hTNF/CHX-treated Rb-MI cells. Rb-wt (⫹/⫹) and Rb-MI (MI/MI) cell lysates were prepared 5 h after the indicated
treatments. Equal amounts of cytosolic protein were resolved by SDS-PAGE and immunoblotted with anti-cytochrome c or anti-Smac. E, Bid is not cleaved in
hTNF/CHX-treated Rb-MI cells. Whole cell lysates were prepared at 5 h after the indicated treatment. Equal amounts of total protein were resolved by
SDS-PAGE, and Bid and tBid were detected by immunoblotting. F, cytosolic extracts from hTNF/CHX-treated Rb-wt but not Rb-MI cells induced cytochrome c
release from liver mitochondria. Cytosolic extracts from cells prepared at the indicated time after hTNF/CHX treatment were incubated with mouse liver
mitochondria at 37 °C for 45 min. Mitochondria were pelleted by centrifugation, and supernatants and pellets were analyzed for cytochrome c and Cox-IV by
immunoblotting. B, buffer-treated mitochondria. G, cytosolic extracts from Rb-MI cells did not interfere with cytochrome c release stimulated by recombinant
truncated Bid (NC-Bid) (46). The indicated extracts from hTNF/CHX-treated (⫹) or untreated (⫺) cells were incubated with liver mitochondria from wild type
mice plus the indicated amounts of NC-Bid, and the incubation mixtures were analyzed for cytochrome c release as in E. H, liver mitochondria from RbMI/MI mice
released cytochrome c in response to cytosolic extract from hTNF/CHX-treated Rb-wt cells. Cytosolic extracts were prepared after the indicated treatment and
incubated with mitochondria isolated from the liver of Rb⫹/⫹ or RbMI/MI mice. Cytochrome c release was examined as in F.
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FIGURE 2. TNF-induced Rb cleavage is dependent on caspase-8 and required for Bid cleavage. A, caspase-8 (p55) is detected in wild-type (Casp8⫹/⫹) but
not caspase-8 knock-out (Casp8⫺/⫺) cells. B, cells with the indicated genotypes were treated with hTNF/CHX for 5 h and analyzed for PARP1 and cleaved
caspase-3 by immunoblotting of whole cell lysates. The cleavage of Rb was detected by immunoprecipitation (IP) and immunoblotting (IB) as described under
“Experimental Procedures.” The levels of actin are shown as loading controls. C and D, DEVDase (C) or IETDase (D) activity was measured in whole cell lysates
after a 5-h treatment of the indicated cells with hTNF/CHX, with the activity in untreated lysates set to 1. Values are mean and S.E. from three independent
experiments. E, the indicated cells were transfected with control siRNA (LacZ) or Rb siRNA, and the level of Rb protein was determined by IP/IB at 48 h
post-transfection. F, Rb siRNA restored death response to hTNF/CHX in Rb-MI MEFs. At 48 h post-transfection with the indicated siRNA, cells of the indicated
genotypes were treated with hTNF/CHX for 5 h, and cell death was determined by the uptake of propidium iodide. Values are mean and S.E. from three
independent experiments. G, Rb siRNA enhanced hTNF/CHX-induced IETDase activity in Rb-MI cells. Cells treated as in F were collected, and the IETDase activity
was measured in whole cell lysates. -Fold changes are relative to LacZ siRNA-transfected and untreated cells for each genotype. Means and S.E. from three
independent experiments are shown. H, Rb siRNA allowed Bid cleavage in hTNF/CHX-treated Rb-MI MEFs. Whole cell lysates from G were analyzed for Bid and
tBid by immunoblotting.

Enhanced Death Response, Caspase Activity, and Bid Cleavage through 4 °C Preincubation with TNF—Recent reports have
suggested that TNFR1 endocytosis is required for the activation
of caspase-8 (16, 17), and synchronized endocytosis enhances
TNFR1-induced caspase-8 activation (16). Synchronized endocytosis can be achieved by preincubating cells with TNF at 4 °C
and then raising the temperature to 37 °C to allow for the simultaneous uptake of ligand-engaged TNFR1 (16). We applied this
protocol to the Rb-wt and Rb-MI cells at varying concentrations
of hTNF and found that synchronization sensitized both cell
types to hTNF/CHX-induced death, measured at 24 h posttemperature shift (Fig. 4, A and B). The preincubation protocol
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also enhanced IETDase activity measured at 2–3 h after the
hTNF/CHX addition (Fig. 4C), corresponding to the cleavage
of Bid (and the formation of tBid) in Rb-MI cells (Fig. 4D).
Although preincubation enhanced the response of Rb-MI cells
to hTNF/CHX, it did not restore the response to that of the
Rb-wt cells. Nevertheless, the partial rescue of Bid cleavage
defect by preincubation suggests that the level of caspase-8 can
be artificially raised in Rb-MI cells by synchronized endocytosis. The endocytosis of TNF receptor should be functional in
Rb-MI cells; otherwise, we would not have been able to sensitize
these cells by preincubation at 4 °C. However, the apoptotic
signal output from the endocytic compartment is lower in
VOLUME 282 • NUMBER 40 • OCTOBER 5, 2007
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both Rb-wt and Rb-MI cells (Fig.
4F). Thus, TNF does not cause a
detectable inhibition of V-ATPase
activity; however, V-ATPase inhibitor can restore TNF-induced IETDase in Rb-MI cells.
Inhibition of V-ATPase Restores
Caspase-8-dependent Bid Cleavage
in Rb-MI Cells—To further examine
the effect of V-ATPase inhibition,
we tested whether Baf can enhance
the activation of caspase-8. Using
the in vivo biotinylation approach
outlined in Fig. 3B, we showed that
Baf did not cause a significant
increase in the pull-down of p55 and
p43 caspase-8 in Rb-wt and Rb-MI
cells (Fig. 5A). However, Baf allowed
the accumulation of cytosolic IETDase activity and the cleavage of Bid
in hTNF/CHX-treated Rb-MI cells
(Fig. 5, B and C). Baf treatment did
not enhance IETDase activity or Bid
cleavage in Rb-wt cells. Bid cleavage
under the condition of Baf plus
hTNF/CHX remained dependent
on caspase-8 (Fig. 5D), showing that
Baf did not activate an alternative
FIGURE 3. In vivo affinity labeling of activated caspase-8 in Rb-wt and Rb-MI cells. A, caspase-8 processing
was not detected in whole cell lysates prepared at 5 h after hTNF/CHX treatment of Rb-wt or Rb-MI MEFs. Bid cleavage pathway. We found
B, outline of the affinity labeling experiments. C, biotinylation of caspase-8. Cells of the indicated genotypes that the levels of TNFR1 and DISC
were treated as in B. The p55 and p43 bands were not present in caspase-8 knock-out MEFs. The levels of actin component proteins were similar in
in the input fractions are shown. D, biotinylation of caspase-8 in Rb-wt and Rb-MI cells. Cells of the indicated
genotypes were collected at the indicated time after hTNF/CHX treatment, whole cell lysates (1 mg of total Rb-wt and Rb-MI cells, and their
protein) were incubated with streptavidin beads, and caspase-8 was detected in the bound fractions by immu- levels were not affected by hTNF/
noblotting. The amounts of p55 caspase-8 in 50 g of each input fraction are also shown.
CHX and/or Baf treatment (Fig. 5E).
We noted that Baf also stimulated
Rb-MI cells than that of Rb-wt cells even under conditions of hTNF/CHX-induced Rip1 cleavage, which is mediated by
caspase-8 (51), in Rb-MI cells but not in Rb-wt cells (Fig. 5E).
synchronized endocytosis.
To seek additional evidence that inhibition of V-ATPase can
One possibility for the Bid cleavage defect might be that activated caspase-8 was lost through endosomal trafficking in restore Bid cleavage in Rb-MI cells, we knocked down the B1
Rb-MI cells. We tested several drugs known to interfere with subunit of the cytosolic V1 complex of the V-ATPase by siRNA.
endocytic trafficking and lysosomal degradation for their The control siRNA did not affect Bid cleavage; however, the
effects on hTNF/CHX-induced IETDase activity in Rb-MI cells knockdown of the V-ATPase B1 subunit rescued hTNF/CHX(Fig. 4E). Four of the compounds tested (i.e. ammonium chlo- induced IETDase activity and Bid cleavage in Rb-MI cells (Fig.
ride (raises intracellular pH), FCCP (a proton ionophore), 5, F–H). Because pretreatment with Baf or V1B1 knockdown
3-methyladenine (3-MA) (an inhibitor of autophagy), and ben- did not enhance hTNF/CHX-induced IETDase or Bid cleavage
zyloxycarbonyl-FF-fmk (an inhibitor of cathepsins)) did not in Rb-wt cells (Fig. 5, B, C, E, F, and G), it suggests that
activate IETDase in the absence or presence of hTNF/CHX V-ATPase inhibition is irrelevant to Bid cleavage when Rb can
(Fig. 4E). Interestingly, we found that concanamycin A and be cleaved. However, in Rb-MI cells, V-ATPase inhibition supbafilomycin A both are inhibitors of V-ATPase and stimulated plants the requirement of Rb cleavage to allow Bid cleavage.
IETDase activity in hTNF/CHX-treated Rb-MI cells but did not
Bafilomycin A1 Stimulates DSS-induced Colonic Apoptosis in
have any effect in the absence of TNF (Fig. 4E). V-ATPase acid- RbMI/MI Mice—We have previously shown that Rb-MI proifies the endosomes to promote their trafficking along the lyso- motes colon tumors in the p53-null genetic background, corresomal degradative pathway (39). We therefore measured the lating with reduced apoptotic response to inflammation-assopH of the endosomal compartment using a pH-sensitive fluo- ciated epithelial apoptosis (52). We induced apoptosis of
rescent dextran (50) and found that hTNF/CHX treatment did colonic epithelial cells by feeding mice with water containing
not affect the endosomal pH in Rb-wt or Rb-MI cells (Fig. 4F). DSS for 3 days (52). Mice were also exposed to Baf via intrapBy contrast, treatment with bafilomycin A1 (Baf) raised the eritoneal injection 16 h prior to the collection of colonic tissue.
endosomal pH from 5.5 to 7 irrespective of TNF treatment in Exposure to DSS induced TUNEL-positive nuclei in the colonic
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epithelium (Fig. 6A). Exposure to Baf alone did not induce apoptosis (not shown). Following DSS exposure, the number of
TUNEL-positive nuclei in the colonic crypts was significantly
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lower in RbMI/MI mice than in Rb⫹/⫹ littermates (Fig. 6B). However, additional exposure to Baf significantly increased the apoptotic response of RbMI/MI mice to DSS feeding. Baf also signifi-
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cantly enhanced the apoptotic response of Rb⫹/MI mice to DSS
(Fig. 6B). By contrast, Baf did not affect the colonic apoptotic
response in Rb⫹/⫹ mice (Fig. 6B). We have previously shown
that thymocytes from RbMI/MI mice are resistant to hTNF/
CHX-induced apoptosis (31). We found that treatment with
Baf also enhanced hTNF/CHX-induced apoptosis of thymocytes from RbMI/MI but not Rb⫹/⫹ mice (not shown). Thus,
Rb-MI-mediated inhibition of TNFR1-dependent apoptosis
can be overridden by Baf in fibroblasts, thymocytes, and colonic
epithelial cells.

DISCUSSION
Sequential Activation of TNFR1-induced Type-1 and Type-2
Apoptotic Pathways—In the current model of extrinsic apoptotic pathways, activation of caspase-8 leads to the simultaneous
cleavage of substrates in the type-1 and the type-2 pathways
(Fig. 7A). This parallel cleavage model cannot explain our
observations with the Rb-MI cells, where caspase-8 is activated
but Bid is not cleaved. Our results suggest an alternative model
where caspase-8-dependent Rb cleavage precedes caspase-8dependent Bid cleavage (Fig. 7B). Because Bid is not cleaved in
Rb-MI cells, we propose that Rb cleavage via the type-1 pathway
is an upstream requirement for Bid cleavage in the type-2 pathway (Fig. 7B).
The sequential cleavage model predicts that Rb cleavage
would not be required for TNF to kill cells that die by the
type-1 pathway alone. In other words, Rb-MI would only
protect type-2 cells from TNF-induced apoptosis. This is
consistent with our previous findings that endotoxin-induced apoptosis is blocked in the intestine but not in the
spleen of Rb-MI mice (30). We would point out that mouse
embryo fibroblasts (MEFs) are type-1 cells, because TNF/
CHX-induced apoptosis is observed in Bid knock-out and
cytochrome c knock-out MEFs (53, 54). In other words, the
Bid-dependent cytochrome c release is not necessary for
TNF/CHX to kill MEFs. In fact, we show that mTNF/CHX
can indeed activate apoptosis in Rb-MI MEFs. Only by activating TNFR1 alone with human TNF could we reveal the
type-2 pathway blockade imposed by Rb-MI in MEFs. The
physiological relevance of the MEF-based experimental
results is demonstrated by our observation that bafilomycin
A1 can restore colonic apoptosis in DSS-treated RbMI/MI
mice. We have found that DSS-induced colonic apoptosis is
diminished in TNFR1-deficient mice,5 suggesting the
involvement of TNFR1 in this in vivo response. This death

response is diminished in Rb⫹/MI and RbMI/MI mice but
could be enhanced by bafilomycin. Taken together, results
from Rb-MI MEFs and RbMI/MI mice are consistent with the
model that Rb cleavage is required for TNF to activate the
type-2 apoptotic pathway.
Receptor Endocytosis and Cytosolic Accumulation of Activated Caspase-8—Previous studies have shown that TNFR1
does not initiate DISC assembly at the plasma membrane (18,
19). Instead, the TNFR1-DISC complex is detected in the
endosomal fraction under conditions of synchronized endocytosis in several cell types (16, 17). A cytosolic DISC free of
TNFR1 has been observed in a human fibrosarcoma cell line
that ectopically expresses a constitutive inhibitor of NF-B
(18). In the fibrosarcoma cell line, two distinct signaling
complexes were identified. Complex-1 contains TNFR1,
TRADD, RIP1, and TRAF2 and mediates NF-B activation.
This membrane complex appears to be further processed to
recruit FADD through TRADD, resulting in the formation of
complex-2 (i.e. the DISC complex), which dissociates from
TNFR1 and accumulates in the cytosol (18). Interestingly,
although TRAIL-induced apoptosis does not require receptor endocytosis (55), internalization of FAS/CD95 and
TNFR1 through endocytosis is required for the induction of
apoptosis (16, 17, 56). Activated FAS/CD95L directly
recruits FADD and stimulates a small amount of DISC formation at the cell surface, followed by endocytosis of the
entire complex. In type-1 cells, this internalization step triggers further recruitment of FADD and caspase-8 to stimulate
apoptosis (56). We have found that Rb-MI does not interfere
with apoptosis induced by anti-FAS or TRAIL (30).6 Rb-MI
does not interfere with TNFR1 endocytosis, because synchronization of endocytosis rescued Bid cleavage in Rb-MI
cells. Taken together, these results suggest that Rb-MI does
not block apoptosis at the step of receptor internalization.
Furthermore, these results suggest that DISC complexes
stimulated by activated Fas versus TNFR1 may be subjected
to different regulation, despite the similar requirement for
receptor endocytosis in the assembly of DISC. Because synchronized endocytosis can enhance caspase-8 activity and
Bid cleavage in MEFs, irrespective of Rb cleavage, and
because the inhibition of V-ATPase specifically enhanced
caspase-8-dependent Bid cleavage in Rb-MI cells, Rb-MI is
likely to exert its antiapoptotic effect by preventing the cyto-

6
5

I. C. Hunton and J. Y. J. Wang, unpublished results.

X. Huang, A. Masselli, S. M. Frisch, I. C. Hunton, Y. Jiang, and J. Y. J. Wang,
unpublished results.

FIGURE 4. Preincubation at 4 °C sensitized Rb-wt and Rb-MI cells to hTNF/CHX. A and B, death response was enhanced by preincubation with
hTNF/CHX at 4 °C. Cell death was measured by propidium iodide uptake at 24 h after treatment with the indicated concentrations of hTNF and CHX (2.5
g/ml) in Rb-MI (A) and Rb-wt (B) cells. Cells were treated with or without a 90-min preincubation at 4 °C followed by warming to 37 °C to induce
synchronized endocytosis. Note that preincubation sensitized Rb-wt and Rb-MI cells to hTNF/CHX-induced death. However, death response was lower
in Rb-MI cells at every hTNF concentration tested. C, IETDase activity was enhanced by preincubation with hTNF/CHX at 4 °C. Rb-wt and Rb-MI cells were
incubated with hTNF (33 ng/ml) plus CHX (2.5 g/ml) at 4 °C for 90 min and then shifted to 37 °C for the indicated times, and the -fold increase in IETDase
activity over untreated cells was determined. D, Bid cleavage was partially restored in Rb-MI cells by preincubation. Cells treated as in C were collected
at 5 h after warming to 37 °C. Whole cell lysates were analyzed for Bid; cytosolic extracts were analyzed for cytochrome c and Smac. E, effects of inhibitors
on IETDase activity in Rb-MI cells. Cells were pretreated with the indicated chemicals for 1 h and then treated with hTNF/CHX for 5 h. IETDase activity was
measured in whole cell lysates, and the activity in untreated cell lysate was set to 1. F, analysis of lysosomal pH. Rb-wt and Rb-MI cells were labeled with
the pH-sensitive FITC-dextran for 1 h and then were treated with hTNF/CHX, with or without 200 nM bafilomycin A1 as described under “Experimental
Procedures.” The pH values were determined by comparing the fluorescence signals with a standard curve constructed for FITC-dextran in phosphate/
citrate buffers of different pH values between 4.0 and 8.0.
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FIGURE 5. Inhibition of V-ATPase restores Bid cleavage in hTNF/CHX-treated Rb-MI MEFs. A, Baf does not significantly affect the biotinylation of caspase-8.
Cells of the indicated genotypes were preincubated with 50 M biotin-VAD-fmk in the absence (⫺) or presence (⫹) of 200 nM Baf for 1 h and then treated with
hTNF/CHX for 5 h. Caspase-8 in the input lysates and in the streptavidin pull-down fractions was measured by immunoblotting. B, Baf-stimulated IETDase
activity in hTNF-treated Rb-MI cells. Cells of the indicated genotypes were preincubated with 200 nM Baf for 1 h followed by hTNF/CHX for 5 h, and IETDase
activity was measured. The activity of untreated cells of each genotype was set to 1. -Fold changes represent means and S.E. values from three experiments.
C, Baf rescued hTNF/CHX-induced Bid cleavage in Rb-MI cells. Cells treated as in B were analyzed for Bid and tBid by immunoblotting of whole cell lysates. D, Baf
does not induce Bid cleavage in caspase-8 knock-out cells. Cells of the indicated genotypes were treated as in B, and whole cell lysates were analyzed for Bid
and tBid by immunoblotting. E, effects of hTNF/CHX and/or Baf on the levels of TNFR1 and DISC components. Rb-wt and Rb-MI cells were treated with or without
hTNF/CHX for 5 h, in the presence or absence of a 1-h preincubation with bafilomycin A1 (200 nM). Whole cell lysates were immunoblotted with the indicated
antibodies. Note that Baf allowed Rip1 cleavage in hTNF/CHX-treated Rb-MI cells. F, knockdown of the B1 subunit in the V1 complex of the mouse V-ATPase
(V1B1). Whole cell lysates collected at 48 h post-transfection with the indicated siRNA were immunoblotted with anti-V1B1 or anti-actin. G and H, knockdown
of V1B1 enhanced IETDase activity (G) and Bid cleavage (H) in Rb-MI cells. At 48 h post-transfection with the indicated siRNA, Rb-MI cells were treated with
hTNF/CHX for 5 h. Whole cell lysates were analyzed for IETDase activity, with the activity in mock-transfected and untreated sample from each genotype set to
1 (G).
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Furthermore, hTNF/CHX treatment did not alter the endosomal
pH in Rb-MI cells. Taken together,
these results suggest that Rb cleavage, mediated by the type-1 pathway, may regulate the release/
sorting of endosomal DISC, but
not the lysosomal degradation of
activated caspase-8, to promote
Bid cleavage.
Mechanism of Rb-dependent Blockade of Bid Cleavage—The nuclear Rb protein inhibits cell proliferation and apoptosis through
transcriptional regulation of E2Fdependent gene expression (58).
Cleavage of Rb at the C-terminal
caspase
site
(DEAD886G887)
mutated in Rb-MI (DEAA886E887)
generates a large Rb-⌬I fragment
(residues 1– 886) that encompasses
the two well-defined E2F-binding
pockets and the Abl-binding
C-pocket in the Rb protein (59, 60).
We have previously shown that
Rb-⌬I is further degraded in apoptotic cells (28, 30), suggesting that
C-terminal cleavage can cause the
loss of Rb protein thus leading to the
activation of proapoptotic gene
expression through E2F and Abl
FIGURE 6. DSS-induced colonic epithelial apoptosis is reduced in RbMI/MI mice but restored by bafilomy- (31, 58). The blockade of Bid cleavcin A1. A, representative images of colonic tissue sections stained with DAPI (blue) or TUNEL (red). Mice of the
indicated genotypes were fed with water containing 3% DSS. At 56 h into DSS feeding, they were injected age observed in this study is not
intraperitoneally with either Baf (25 ng/g body weight) or vehicle (phosphate-buffered saline). Mice were likely to involve new gene expressacrificed 16 h after injection, and colonic apoptosis was quantitated as described under “Experimental Prosion, because Rb-⌬I was not further
cedures.” B, density of TUNEL-positive nuclei. The number of TUNEL-positive nuclei per crypt was determined
by counting at least 25 full crypts or 50 half crypts in 3–5 sections/sample. The number of mice in each degraded at the time point when Bid
experimental group is shown, and the p values were determined by t test assuming unequal variances.
cleavage occurred and because
cycloheximide was used in conjuncsolic accumulation of activated caspase-8 downstream of tion with TNF to induce cell death.
TNFR1 activation.
We have previously shown that thymocytes from Abl- or
We propose that the endosomal TNFR1䡠DISC complex may p73-deficient mice are resistant to TNF-induced apoptosis
activate the type-1 pathway in a manner similar to that of the (31). With Abl- or p73-deficient mouse fibroblasts, TNF/CHXendosomal FAS-DISC complex in type-1 cells (56) (Fig. 7B).
induced apoptosis was not abolished; nevertheless, reintroducThe endosomal DISC can then be released from the receptor to
tion of Abl or p73 could enhance the death response in these
accumulate as cytosolic DISC or shunted down the endocytic
knock-out cells by stimulating cytochrome c release (31).
degradation pathway (Fig. 7B). We propose that only the cytoAlthough Abl enhances TNF/CHX-induced fibroblast cell
solic DISC is competent in cleaving Bid. We propose that the
majority of activated caspase-8 is lost through endocytic traf- death, we found that the ectopic activation of Abl tyrosine
ficking in Rb-MI cells, thus causing the lack of cytosolic IET- kinase through inducible dimerization (61) in Rb-MI cells did
Dase activity and the defect in Bid cleavage. Consistent with not rescue the hTNF/CHX-induced IETDase activity (supplethis notion is the finding that pharmacological or genetic mental Fig. 3). However, the ectopic activation of the same
ablation of the V-ATPase can restore cytosolic IETDase and dimerizable Abl kinase could stimulate IETDase in hTNF
Bid cleavage in Rb-MI cells. Inhibition of V-ATPase prevents (without cycloheximide)-treated p21E cells, which lack
endosomal fusion with multivesicular bodies and lysosome p21Cip1 and express the adenoviral E1A protein (supplemental
as well as endosomal degradation (39, 57). The rescuing of Fig. 3). Furthermore, siRNA-mediated knockdown of Abl did
IETDase or Bid cleavage was not observed with drugs that not interfere with hTNF/CHX-induced IETDase activity in
raise the intracellular pH (NH4Cl, FCCP), inhibit autophagy Rb-wt cells (supplemental Fig. 3). Whereas Abl contributes to
(3-MA), or inhibit cathepsins (benzyloxycarbonyl-FF-fmk). TNF-induced type-2 apoptosis, results from this study suggest
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FIGURE 7. Parallel versus sequential cleavage in extrinsic apoptotic pathways. The current model of extrinsic apoptosis suggests parallel cleavage of
substrates in the type-1 and the type-2 pathways by receptor-activated DISC. This model cannot explain our finding that Rb cleavage is required for Bid
cleavage. We propose a sequential cleavage model, in which Rb is cleaved through the type-1 pathway, and its cleavage is a prerequisite for DISC to cleave Bid.
In Rb-MI cells where Rb cannot be cleaved, the endosomal TNFR1-DISC complex is lost through V-ATPase-dependent endocytic trafficking. Our data suggest
that Rb cleavage may cause the release of a nuclear factor that either blocks endosomal trafficking of TNFR1-DISC or stimulates DISC dissociation from the
endosomal-TNFR1 to allow for Bid cleavage. The sequential cleavage model can explain why Rb cleavage is not required for TNF-induced apoptosis in type-1
cells. Rb cleavage may serve as a nuclear checkpoint for TNF-induced type-2 apoptosis.

that the blockade of Bid cleavage in Rb-MI cells is mediated
through Abl-independent mechanisms.
We considered two possibilities for how Rb cleavage might
stimulate caspase-8-dependent Bid cleavage. In the first scenario, the cleaved products (Rb-⌬I and/or the C-terminal 41amino acid peptide) exert a positive effect on caspase-8 and Bid
cleavage. In the second scenario, cleavage of Rb causes the
release of a factor that stimulates the cytosolic accumulation of
caspase-8, thus leading to Bid cleavage. The first scenario that
Rb fragments directly activate caspase-8 or Bid cleavage is
inconsistent with the result that knockdown of Rb-MI rescued cytosolic caspase-8 activity and Bid cleavage. Furthermore, knockdown of Rb-wt did not affect hTNF/CHX-induced caspase-8 activation or Bid cleavage, suggesting that
Rb fragments are not required for Bid cleavage. Although we
currently favor the second scenario (i.e. Rb cleavage causes
the release of a factor (X in Fig. 7B) to stimulate Bid cleavage), we do not know the identity of such a factor. A previous
report has shown that Rb-⌬I loses the ability to bind MDM2
(62). There is considerable evidence in the literature that
MDM2 functions as an inhibitor of apoptosis (63), thus

29412 JOURNAL OF BIOLOGICAL CHEMISTRY

inconsistent with MDM2 being an activator of the TNFinduced type-2 apoptotic pathway. Identification of the
mechanism by which Rb-MI blocks Bid cleavage awaits further investigation.
Rb Cleavage as a Nuclear Checkpoint for TNF-induced
Type-2 Apoptosis—The sequential model depicted in Fig. 7B
suggests that cleavage of Rb may serve as a nuclear checkpoint
for the activation of the type-2 apoptotic pathway by TNF. Previous studies have suggested that hyperphosphorylated Rb is
more resistant to caspase cleavage (59, 64). If so, Rb cleavage is
less likely to occur in S/G2/M phase cells that contain hyperphosphorylated Rb. Since TNF activates NF-B, which promotes cell growth and survival, the Rb cleavage checkpoint may
help to prevent the activation of the type-2 apoptotic pathway
during TNF-stimulated cell proliferation. We have found that
DSS induced colonic apoptosis to occur preferentially in the
differentiated and nonproliferating epithelial cells, and it is this
population of cells that are protected from apoptosis in the
RbMI/MI mice. The status of the Rb protein (i.e. phosphorylation
versus degradation) may therefore regulate the proliferative
versus apoptotic response to TNF.
VOLUME 282 • NUMBER 40 • OCTOBER 5, 2007
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